Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemod
ClinicalTrials.gov study NCT01876381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
ClinicalTrials.gov study NCT01626781. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
ClinicalTrials.gov study NCT00034658. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
ClinicalTrials.gov study NCT05161715. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
ClinicalTrials.gov study NCT00182013. IPD Sharing: Not stated. Countries: 0. Publications: 1.
An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)
ClinicalTrials.gov study NCT01458249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
ClinicalTrials.gov study NCT00806546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
ClinicalTrials.gov study NCT01603641. IPD Sharing: Not stated. Countries: 9. Publications: 0.
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
ClinicalTrials.gov study NCT00652080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)
ClinicalTrials.gov study NCT05472870. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase
ClinicalTrials.gov study NCT01141283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
ClinicalTrials.gov study NCT00592683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
ClinicalTrials.gov study NCT00659126. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment
ClinicalTrials.gov study NCT04480827. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
ClinicalTrials.gov study NCT00115128. IPD Sharing: Not stated. Countries: 0. Publications: 1.
TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on t
ClinicalTrials.gov study NCT00650832. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Dail
ClinicalTrials.gov study NCT01915914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
WR 279,396 Open Label Treatment Protocol in Tunisia
ClinicalTrials.gov study NCT01494350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)
ClinicalTrials.gov study NCT01684202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT00521404. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.